Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE SWISS HIP REPLACEMENT IMPLANTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 3D HIP MARKET & NAVIGATION/COMPUTERIZED SURGERY
5 EUROPE HIP REPLACEMENT IMPLANTS MARKET
5.1 OVERVIEW
5.2 EXECUTIVE SUMMARY
5.3 REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 A RISE IN THE PREVALENCE OF HIP ARTHRITIS
6.1.2 GOVERNMENT AND PRIVATE INITIATIVES FOR HEALTHCARE AND INSURANCE INVESTMENTS
6.1.3 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES AND CEMENTLESS IMPLANTS
6.1.4 REVISION OF IMPLANTS
6.2 RESTRAINTS
6.2.1 PRODUCT RECALLS AND PRODUCT FAILURES
6.2.2 COMPLICATIONS OF IMPLANTS
6.3 OPPORTUNITIES
6.3.1 RISING PRODUCT INNOVATIONS AND DEVELOPMENT OWING TO TECHNOLOGICAL ADVANCEMENTS
6.3.2 RISING ADOPTION OF CUSTOMIZED HIP PROSTHESIS
6.3.3 INCREASE IN ADOPTION OF NAVIGATED AND ROBOTICS IN HIP REPLACEMENT PROCEDURES
6.4 CHALLENGES
6.4.1 HIGH COSTS ASSOCIATED WITH HIP REPLACEMENTS AND IMPLANTS
6.4.2 STRINGENT REGULATORY FRAMEWORK
7 SWISS HIP REPLACEMENT IMPLANTS MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 TOTAL REPLACEMENT IMPLANTS
7.3 FEMORAL RECONSTRUCTION
7.4 ACETABULAR RECONSTRUCTION
7.5 HIP RESURFACING
7.6 REVISION HIP IMPLANTS
7.7 BEARING AND POROUS METAL TECHNOLOGIES
8 SWISS HIP REPLACEMENT IMPLANTS MARKET, BY MATERIAL
8.1 OVERVIEW
8.2 CERAMIC-ON-METAL
8.3 METAL-ON-POLYETHYLENE
8.4 METAL-ON-METAL
8.5 CERAMIC-ON-POLYETHYLENE
8.6 CERAMIC-ON-CERAMIC
9 SWISS HIP REPLACEMENT IMPLANTS MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS & SURGERY CENTERS
9.3 ORTHOPEDIC CLINICS
9.4 OTHERS
10 SWISS HIP REPLACEMENT IMPLANTS MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT SALES
10.3 RETAIL SALES
10.4 ONLINE PHARMACY AND E-COMMERCE
11 SWISS HIP REPLACEMENT IMPLANTS MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: SWITZERLAND
12 SWOT ANALYSIS
13 COMPANY PROFILE
13.1 STRYKER
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENT
13.2 SMITH & NEPHEW
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 PRODUCT PORTFOLIO
13.2.4 RECENT DEVELOPMENT
13.3 ZIMMER BIOMET
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT DEVELOPMENTS
13.4 MEDACTA INTERNATIONAL
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 PRODUCT PORTFOLIO
13.4.4 RECENT DEVELOPMENT
13.5 DEPUY SYNTHES COMPANIES (A PART OF JHONSON & JHONSON MEDICAL DEVICES COMPANIES) (2022)
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENT
13.6 ATESOS
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENT
13.7 B. BRAUN MELSUNGEN AG
13.7.1 COMPANY SNAPSHOT
13.7.2 REVENUE ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENT
13.8 CORIN GROUP
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENT
13.9 CONFORMIS (2022)
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENT
13.1 D.J.O., LLC
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.10.3 RECENT DEVELOPMENT
13.11 EXACTECH, I.N.C.
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENT
13.12 KYOCERA MEDICAL TECHNOLOGIES, INC. (2022)
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT DEVELOPMENT
13.13 MICROPORT SCIENTIFIC CORPORATION (2022)
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENT
13.14 MATHYS LTD BETTLACH
13.14.1 COMPANY SNAPSHOT
13.14.2 PRODUCT PORTFOLIO
13.14.3 RECENT DEVELOPMENT
13.15 SYMBIOS ORTHOPEDIE S.A.
13.15.1 COMPANY SNAPSHOT
13.15.2 PRODUCT PORTFOLIO
13.15.3 RECENT DEVELOPMENTS
13.16 WALDEMAR LINK GMBH & CO. KG
13.16.1 COMPANY SNAPSHOT
13.16.2 PRODUCT PORTFOLIO
13.16.3 RECENT DEVELOPMENT
14 QUESTIONNAIRE
15 RELATED REPORTS
List of Table
TABLE 1 EUROPE HIP REPLACEMENT IMPLANTS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 EUROPE HIP REPLACEMENT IMPLANTS MARKET, BY MATERIAL, 2021-2030 (USD MILLION)
TABLE 3 EUROPE HIP REPLACEMENT IMPLANTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 4 EUROPE HIP REPLACEMENT IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 5 FACTORS AND VARIABLES COLLECTED BY THE SIRIS FOR THE REGISTRY OF IMPLANTS
TABLE 6 SWISS HIP REPLACEMENT IMPLANTS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 SWISS HIP REPLACEMENT IMPLANTS MARKET, BY MATERIAL, 2021-2030 (USD MILLION)
TABLE 8 SWISS HIP REPLACEMENT IMPLANTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 9 SWISS HIP REPLACEMENT IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 SWISS HIP REPLACEMENT IMPLANTS MARKET: SEGMENTATION
FIGURE 2 SWISS HIP REPLACEMENT IMPLANTS MARKET: DATA TRIANGULATION
FIGURE 3 SWISS HIP REPLACEMENT IMPLANTS MARKET: DROC ANALYSIS
FIGURE 4 SWISS HIP REPLACEMENT IMPLANTS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 SWISS HIP REPLACEMENT IMPLANTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 SWISS HIP REPLACEMENT IMPLANTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 SWISS HIP REPLACEMENT IMPLANTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 SWISS HIP REPLACEMENT IMPLANTS MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 SWISS HIP REPLACEMENT IMPLANTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 SWISS HIP REPLACEMENT IMPLANTS MARKET: SEGMENTATION
FIGURE 11 THE RISE IN THE PREVALENCE OF HIP ARTHRITIS IS EXPECTED TO DRIVE THE SWISS HIP REPLACEMENT IMPLANTS MARKET IN THE FORECAST PERIOD
FIGURE 12 TOTAL REPLACEMENT IMPLANTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST MARKET SHARE OF THE SWISS HIP REPLACEMENT IMPLANTS MARKET IN 2023 AND 2030
FIGURE 13 CLASSIFICATION OF COMPUTER-ASSISTED ORTHOPEDIC SURGERY (CAOS)
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE SWISS HIP REPLACEMENT IMPLANTS MARKET
FIGURE 15 ADVANTAGES OF MINIMALLY INVASIVE HIP REPLACEMENT SURGERIES
FIGURE 16 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY PRODUCT TYPE, 2022
FIGURE 17 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 18 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 19 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 20 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY MATERIAL, 2022
FIGURE 21 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY MATERIAL, 2023-2030 (USD MILLION)
FIGURE 22 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY MATERIAL, CAGR (2023-2030)
FIGURE 23 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY MATERIAL, LIFELINE CURVE
FIGURE 24 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY END USER, 2022
FIGURE 25 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 26 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 27 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 28 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 29 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 30 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 31 SWISS HIP REPLACEMENT IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 32 SWISS HIP REPLACEMENT IMPLANTS MARKET: COMPANY SHARE 2022 (%)
